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Corrigendum
Zoellner  Y, Balp MM, Gili Marco A. The role of galenic innovation 
in improving treatment compliance and persistence: three case 
studies. Clinicoecon Outcomes Res. 2011;3:109–116.
In the results section of the abstract, “…+15% in Germany 
for desferrioxamine vs deferasirox.” should read “…+15% in 
Germany for deferasirox vs desferrioxamine.”
In the ‘Compliance’ section, “…and +15% in Germany for 
desferrioxamine vs deferasirox.” should read “…and +15% 
in Germany for deferasirox vs desferrioxamine.”